What is a core needle ... carcinoma. Some tumors stay in the place where they started. But tumors can spread to other parts of the breast or the body. The cancer stays in the breast tissue where it ...

Since vaulting onto the scene with the late-stage acquisition of taletrectinib only last year, NUVB has moved deep into contention as an important lung cancer drug developer. Given that their data ...

When stage 0 cancer is discovered in breast tissue, it is typically called ductal carcinoma in situ, or DCIS. DCIS only progresses to stage I, II, III, or IV cancer when it bursts through the milk ...

2014;15(11):1507-1518. Taken together, these studies have firmly established RAF, PI3K and RAL signaling as key downstream effectors of KRAS that promote lung tumorigenesis. While other direct RAS ...

Data from the phase 2 ROME trial were presented by Andrea Botticelli, MD, during the ESMO Targeted Anticancer Therapies ...

Any additional material can be combined with material rinsed from the needle and spun down to form ... Firm nodules are usually suspicious for carcinoma whereas fluctuant or soft nodules suggest ...

A percutaneous biopsy of suspected upper tract urothelial carcinoma (UTUC) is considered contraindicated due to potential safety concerns. This study evaluated the risk of tumor seeding along the ...

(UroToday.com) The 2025 AUA annual meeting featured an engineering and urology session and a presentation by Dr. Eric Gwynn discussing a novel core needle biopsy instrument designed for targeted ...

Department of Thoracic Surgery, Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Background: This study aims to investigate serum metabolite changes in patients with ...

The QUILT-3.032 trial showed a 71% complete response rate in patients with BCG-unresponsive bladder carcinoma in situ treated with NAI. NAI treatment demonstrated a cystectomy-free rate of 84% at 36 ...